Spinocerebellar Ataxia Type 1: Clinical Trials

13 trials for Spinocerebellar Ataxia Type 1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 2 active not recruiting, 2 unknown. 3 Not applicable, 3 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Unknown 1
Phase 23Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 32Active not recruiting 2
Phase 11Recruiting 1

Follow Spinocerebellar Ataxia Type 1: new trials by email Literature Review of Spinocerebellar Ataxia Type 1 trials Research Report on Spinocerebellar Ataxia Type 1

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia
Intravenous infusion, Intrathecal injection, umbilical cord mesenchymal stem cell - Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2
Phase 2Not yet recruitingSclnow Biotechnology Co., Ltd.452026-12-312026-04-23
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
VO659 - Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3
Phase 1 / Phase 2RecruitingVico Therapeutics B. V.682023-02-142026-08-19
Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia
High-Intensity Aerobic Exercise Prior to Balance Training, Low-Intensity Exercise Prior to Balance Training - Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2
Not applicableUnknownTeachers College, Columbia University202023-02-062024-05-03
Study of CAD-1883 for Spinocerebellar Ataxia
CAD-1883, Placebos - Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1
Phase 2WithdrawnCadent Therapeutics2021-06-012021-04-08
Instrumented Data Exchange for Ataxia Study
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2
CompletedUniversity of Chicago1282019-06-012024-08-05
Troriluzole in Adult Participants With Spinocerebellar Ataxia
troriluzole, Placebo - Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1
Phase 3Active not recruitingBiohaven Pharmaceuticals, Inc.2992019-03-082026-06-24
Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia
Anodal cerebellar and cathodal spinal tDCS, Sham cerebellar and sham spinal tDCS - Ataxia, Spinocerebellar Ataxias
Not applicableCompletedAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia612018-12-012021-03-19
Clinical Trial Readiness for SCA1 and SCA3
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia 3
UnknownThe Methodist Hospital Research Institute2002018-08-162022-01-19
Open Pilot Trial of BHV-4157
BHV-4157 - Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1
Phase 3Active not recruitingUniversity of California, Los Angeles242017-12-152024-05-09
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia
Anodal cerebellar and cathodal spinal tDCS, Sham cerebellar and sham spinal tDCS - Ataxia, Cerebellar, Cerebellar Ataxia
Not applicableCompletedAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia212017-02-062020-03-03
Biomarkers in Autosomal Dominant Cerebellar Ataxia
metabolic and imaging biomarkers in SCA1,2,3 and 7 patients - Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2
CompletedAssistance Publique - Hôpitaux de Paris1022011-11-012019-09-06
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingSanford Health200002010-07-012026-10-28
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
Genetic Testing, Blood Collection, Magnetic Resonance Imaging (MRI) Scan - Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2
RecruitingLauren Moore14002010-04-012026-08-03

Narrower conditions

Spinocerebellar Ataxias (13)  ·  Machado-Joseph Disease (12)  ·  Ataxia (5)  ·  Spinocerebellar Ataxia 10 (4)  ·  Spinocerebellar ataxia 8 (4)  ·  Friedreich Ataxia (3)  ·  Multiple System Atrophy (3)  ·  Spinocerebellar Degenerations (3)  ·  Spinocerebellar ataxia, autosomal recessive 1 (3)  ·  Cerebellar Ataxia (2)  ·  Episodic Ataxia, Type 7 (2)  ·  Olivopontocerebellar Atrophy V (2)  ·  Spinocerebellar ataxia, autosomal recessive 3 (2)  ·  3-Methylglutaconic Aciduria, Type V (1)  ·  Achalasia Addisonianism Alacrimia syndrome (1)

Broader conditions

Brain Diseases (13)  ·  Central Nervous System Diseases (13)  ·  Cerebellar Diseases (13)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (13)  ·  Dyskinesias (13)  ·  Genetic Diseases, Inborn (13)  ·  Heredodegenerative Disorders, Nervous System (13)  ·  Nervous System Diseases (13)  ·  Neurodegenerative Diseases (13)  ·  Neurologic Manifestations (13)  ·  Spinal Cord Diseases (13)  ·  Cerebellar Ataxia (11)  ·  Spinocerebellar Degenerations (10)  ·  Ataxia (8)  ·  Pathological Conditions, Signs and Symptoms (6)

Interventions

Blood Specimen Collection (1)  ·  Genetic Testing (1)  ·  Infusions, Intravenous (1)  ·  Injections, Spinal (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Metabolic Networks and Pathways (1)  ·  Surveys and Questionnaires (1)

Sponsors

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Biohaven Pharmaceuticals, Inc. (1)  ·  Cadent Therapeutics (1)  ·  Lauren Moore (1)  ·  Sanford Health (1)  ·  Sclnow Biotechnology Co., Ltd. (1)  ·  Teachers College, Columbia University (1)  ·  The Methodist Hospital Research Institute (1)  ·  University of California, Los Angeles (1)  ·  University of Chicago (1)  ·  Vico Therapeutics B. V. (1)

Countries

United States (8)  ·  France (2)  ·  Italy (2)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Germany (1)  ·  Israel (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Alberto Benussi, MD (2)  ·  Barbara Borroni, MD (2)  ·  Vikram Shakkottai, MD, PhD (2)  ·  Alexandra Durr, MD, PhD (1)  ·  Ali G Hamedani, MD, PhD (1)  ·  Chelsea E Macpherson, DPT (1)  ·  Chiadikaobi Onyike, MD (1)  ·  Christopher Gomez, MD, PhD (1)  ·  Eva-Maria Ratai, MD (1)  ·  George Wilmot, MD, PhD (1)  ·  Gulin Oz, MD (1)  ·  Hank Paulson, MD, PhD (1)  ·  Haris I Sair, MD (1)

Results publications

PMID 25449974, PMID 25773989, PMID 26644294, PMID 26943780, PMID 27848087, PMID 29057148, PMID 29089256, PMID 29106465, PMID 29922574, PMID 30135258, PMID 32982927, PMID 33636389, PMID 33951232, PMID 34115419, PMID 35962273, PMID 36797067, PMID 38489195, PMID 38615323, PMID 38814532, PMID 39806095, PMID 40665587, PMID 40679685, PMID 41445681, PMID 42301528